Trials / Sponsors / Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomyci Bladder Neoplasm, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma | Phase 3 | 2010-11-01 |
| Withdrawn | First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC Bladder Cancer | Phase 3 | 2010-01-01 |
| Completed | Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder C Bladder Neoplasms | Phase 2 / Phase 3 | 2006-11-01 |